Examkin

Question

Difficulty: Very hardHemodynamic and Coagulation Processes

Match each patient's clinical presentation and advanced hemostatic laboratory findings with the correct underlying pathophysiological mechanism of their coagulation disorder.

  • A 68-year-old female presents with spontaneous, extensive ecchymoses. Labs show an isolated prolonged aPTT. A 1:1 mixing study with normal plasma shows complete immediate correction, but the aPTT re-prolongs significantly after 2 hours of incubation at 37°C.Development of autoantibodies that exhibit time- and temperature-dependent inhibition of the intrinsic tenase complex.
  • A 29-year-old female with a history of recurrent mid-trimester fetal loss presents with deep vein thrombosis. Labs show an isolated prolonged aPTT. A 1:1 mixing study demonstrates no correction of the aPTT immediately or after incubation.Presence of immunoglobulins that inhibit in vitro phospholipid-dependent coagulation but promote in vivo thrombosis.
  • A 35-year-old asymptomatic male is evaluated prior to a tonsillectomy. Labs reveal an isolated prolonged aPTT. A 1:1 mixing study demonstrates complete correction of the aPTT immediately, and the correction is maintained after 2 hours of incubation.Autosomal recessive trait causing reduced synthesis of a zymogen that bridges the contact system to the amplification phase.
  • A 22-year-old female presents with severe menorrhagia and borderline thrombocytopenia. Her PT and aPTT are normal. Platelet aggregometry demonstrates an enhanced aggregation response to low-dose ristocetin.Qualitative defect causing pathological hyper-affinity between a bridging glycoprotein and the platelet surface receptor.

Answer

The correct pairings match the time-dependent inhibitor presentation with Acquired Hemophilia A, the immediate inhibitor presentation with Lupus Anticoagulant, the sustained correction presentation with Factor XI deficiency, and the enhanced low-dose ristocetin response with Type 2B von Willebrand disease.
Each advanced laboratory finding corresponds uniquely to a specific pathophysiological mechanism. Time-dependent mixing study correction failures are driven by Factor VIII autoantibodies. Immediate mixing study failures in pro-thrombotic patients are driven by antiphospholipid antibodies. Complete, sustained mixing study corrections represent true zymogen deficiencies. Enhanced low-dose ristocetin responses point directly to the hyper-affinity glycoprotein defect of Type 2B vWD.

Step-by-Step Solution

1
Analyze the immediate vs. incubated mixing study results to differentiate factor deficiencies from specific inhibitors.
Sustained correction indicates a factor deficiency. Immediate failure to correct indicates an immediate inhibitor. Initial correction followed by failure after 2 hours indicates a time-dependent inhibitor.
Normal plasma provides 50% factor levels, correcting a deficiency. Immediate inhibitors (like lupus anticoagulant) neutralize immediately, while Factor VIII autoantibodies require incubation at physiological temperatures to fully neutralize the factor in vitro.
2
Differentiate the clinical consequences of the specific inhibitors.
The immediate inhibitor (lupus anticoagulant) is paradoxically pro-thrombotic in vivo, explaining the recurrent fetal loss and DVT. The time-dependent inhibitor (Acquired Hemophilia A) causes severe spontaneous bleeding.
Lupus anticoagulants target phospholipid-binding proteins, causing endothelial activation in vivo. Factor VIII autoantibodies completely disrupt the intrinsic tenase complex, severely impairing in vivo hemostasis.
3
Interpret the specialized platelet aggregometry combined with the clinical presentation.
Normal coagulation times combined with thrombocytopenia and enhanced low-dose ristocetin-induced platelet aggregation (RIPA) definitively identifies Type 2B von Willebrand disease.
Unlike standard vWD which shows reduced RIPA, Type 2B involves a gain-of-function mutation. The mutant vWF spontaneously binds platelets in vivo, clearing them from circulation (causing thrombocytopenia) and reacting aggressively to even trace amounts of ristocetin in vitro.

Key Concept

Interpretation of immediate vs. incubated mixing studies and platelet aggregometry to diagnose complex coagulopathies.
Rate this question

Topics

Hemodynamic and Coagulation Processes

More questions from this topic